News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
617,540 Results
Type
Article (50390)
Company Profile (235)
Press Release (566900)
Multimedia
Podcasts (145)
Webinars (22)
Section
Business (160240)
Career Advice (3103)
Deals (29115)
Drug Delivery (131)
Drug Development (78948)
Employer Resources (184)
FDA (14686)
Job Trends (12744)
News (287959)
Policy (27900)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2521)
Academic (1)
Accelerated approval (39)
Adcomms (31)
Allergies (141)
Alliances (42929)
ALS (172)
Alzheimer's disease (1591)
Antibody-drug conjugate (ADC) (372)
Approvals (14944)
Artificial intelligence (549)
Autoimmune disease (167)
Automation (40)
Bankruptcy (255)
Best Places to Work (10370)
BIOSECURE Act (19)
Biosimilars (189)
Biotechnology (166)
Bladder cancer (176)
Brain cancer (67)
Breast cancer (694)
Cancer (5281)
Cardiovascular disease (371)
Career advice (2636)
Career pathing (42)
CAR-T (304)
CDC (38)
Celiac Disease (1)
Cell therapy (778)
Cervical cancer (39)
Clinical research (67311)
Collaboration (1742)
Company closure (4)
Compensation (1003)
Complete response letters (71)
COVID-19 (2682)
CRISPR (91)
C-suite (760)
Cystic fibrosis (142)
Data (6330)
Decentralized trials (1)
Denatured (36)
Depression (148)
Diabetes (445)
Diagnostics (6252)
Digital health (43)
Diversity (11)
Diversity, equity & inclusion (42)
Drug discovery (263)
Drug pricing (174)
Drug shortages (22)
Duchenne muscular dystrophy (214)
Earnings (68417)
Editorial (65)
Employer branding (25)
Employer resources (160)
Events (98904)
Executive appointments (850)
FDA (17721)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1398)
Gene editing (196)
Generative AI (46)
Gene therapy (605)
GLP-1 (970)
Government (4700)
Grass and pollen (8)
Guidances (363)
Healthcare (16951)
HIV (65)
Huntington's disease (45)
IgA nephropathy (82)
Immunology and inflammation (252)
Immuno-oncology (72)
Indications (124)
Infectious disease (2959)
Inflammatory bowel disease (197)
Inflation Reduction Act (13)
Influenza (123)
Intellectual property (246)
Interviews (623)
IPO (14715)
IRA (44)
Job creations (2696)
Job search strategy (2118)
JPM (68)
Kidney cancer (19)
Labor market (88)
Layoffs (475)
Leadership (44)
Legal (5284)
Liver cancer (100)
Longevity (15)
Lung cancer (715)
Lymphoma (389)
Machine learning (44)
Management (63)
Manufacturing (739)
MASH (167)
Medical device (10624)
Medtech (10667)
Mergers & acquisitions (15445)
Metabolic disorders (1242)
mRNA (190)
Multiple sclerosis (169)
NASH (23)
Neurodegenerative disease (329)
Neuropsychiatric disorders (91)
Neuroscience (2840)
Neurotech (1)
NextGen: Class of 2026 (5753)
Non-profit (4127)
Now hiring (61)
Obesity (583)
Opinion (319)
Ovarian cancer (175)
Pain (187)
Pancreatic cancer (251)
Parkinson's disease (279)
Partnered (31)
Patents (480)
Patient recruitment (519)
Peanut (51)
People (45278)
Pharmaceutical (59)
Pharmacy benefit managers (26)
Phase 1 (21326)
Phase 2 (29717)
Phase 3 (22049)
Pipeline (5638)
Policy (286)
Postmarket research (2283)
Preclinical (9124)
Press Release (52)
Prostate cancer (272)
Psychedelics (49)
Radiopharmaceuticals (307)
Rare diseases (901)
Real estate (4235)
Recruiting (78)
Regulatory (22328)
Reports (51)
Research institute (2401)
Resumes & cover letters (501)
Rett syndrome (30)
RNA editing (16)
RSV (76)
Schizophrenia (156)
Series A (229)
Series B (173)
Service/supplier (9)
Sickle cell disease (103)
Special edition (29)
Spinal muscular atrophy (155)
Sponsored (42)
Startups (3116)
State (2)
Stomach cancer (21)
Supply chain (87)
Tariffs (78)
The Weekly (107)
Vaccines (1036)
Venture capital (91)
Weight loss (381)
Women's health (85)
Worklife (23)
Date
Today (147)
Last 7 days (837)
Last 30 days (2581)
Last 365 days (28314)
2026 (4658)
2025 (28589)
2024 (33227)
2023 (37848)
2022 (48388)
2021 (52204)
2020 (50069)
2019 (41751)
2018 (31645)
2017 (29666)
2016 (28361)
2015 (33079)
2014 (25140)
2013 (20527)
2012 (21173)
2011 (21721)
2010 (19875)
Location
Africa (835)
Alabama (79)
Alaska (6)
Arizona (195)
Arkansas (10)
Asia (41383)
Australia (6970)
California (10820)
Canada (3305)
China (1144)
Colorado (441)
Connecticut (458)
Delaware (341)
Europe (85424)
Florida (1593)
Georgia (335)
Hawaii (3)
Idaho (44)
Illinois (777)
India (64)
Indiana (488)
Iowa (20)
Japan (445)
Kansas (116)
Kentucky (34)
Louisiana (22)
Maine (80)
Maryland (1330)
Massachusetts (7819)
Michigan (294)
Minnesota (491)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (20)
Nevada (115)
New Hampshire (69)
New Jersey (2982)
New Mexico (25)
New York (2911)
North Carolina (1318)
North Dakota (7)
Northern California (5363)
Ohio (294)
Oklahoma (15)
Oregon (39)
Pennsylvania (2043)
Puerto Rico (19)
Rhode Island (31)
South America (1057)
South Carolina (61)
Southern California (4225)
Tennessee (126)
Texas (1660)
United States (37943)
Utah (313)
Vermont (1)
Virginia (255)
Washington D.C. (66)
Washington State (894)
West Virginia (3)
Wisconsin (107)
617,540 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson
February 17, 2026
·
7 min read
Press Releases
Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
February 9, 2026
·
6 min read
Press Releases
Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson
February 5, 2026
·
6 min read
Press Releases
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
January 20, 2026
·
5 min read
Press Releases
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
December 24, 2025
·
6 min read
Press Releases
Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference
November 24, 2025
·
5 min read
Press Releases
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson
November 19, 2025
·
6 min read
Press Releases
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
November 27, 2025
·
5 min read
Press Releases
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
September 15, 2025
·
6 min read
Press Releases
Can-Fite Reports H1 2025 Financial Results and Clinical Update
August 29, 2025
·
11 min read
1 of 61,754
Next
